It has been demonstrated in MPN and also in other tumors, that MSCs expressing the marker Nestin directly support cell survival and chemoresistance by increasing oxidative phosphorylation (OXPHOS) and simultaneously provide with key antioxidant tools necessary to balance ROS levels during chemotherapy (63–65). This evidence concerns the gene NES and myeloproliferative neoplasm.